Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice

Robert Hitzemann, Y. Qian, B. Hitzemann

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) selected lines of mice differ more than 10-fold in the ED50 for catalepsy induced by a wide variety of neuroleptics with a high dopamine D2/D1 receptor activity ratio, e.g., haloperidol. The NR and NNR lines also differ significantly in dopamine D2 somatodendritic receptor density; within the substantia nigra zona compacta and the ventral tegmental area, the increases in the NNR line are on average 33 and 48%, respectively. We now report that the NNR line has a higher number of dopamine neurons in the midrostral to the midcaudal aspect of the substantia nigra zona compacta. Within this region, the increase in dopamine cell number was on average 41%. In contrast to these data, there was no difference in cell number between lines in the ventral tegmental area. Thus, the increase of midbrain dopamine D2 receptor density in the NNR line can only be accounted for in part by an increase in the number of dopamine neurons. Although the number of dopamine neurons in the substantia nigra zona compacta was increased in the NNR line, the density of dopamine terminals in the caudate-putamen as estimated by the [3H] mazindol technique was modestly but significantly higher (8%) in the NR line. The selected lines also differed within the caudate-putamen in the number of cholinergic neurons. The NR line had a significantly higher number of cholinergic neurons in the rostral caudate-putamen. Overall, these data illustrate that selective breeding for neuroleptic response has yielded lines of mice with significant differences in both the cholinergic and dopaminergic systems of the basal ganglia.

Original languageEnglish (US)
Pages (from-to)431-438
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume266
Issue number1
StatePublished - 1993
Externally publishedYes

Fingerprint

Antipsychotic Agents
Acetylcholine
Dopamine
Cell Count
Dopamine D2 Receptors
Dopaminergic Neurons
Putamen
Herpes Zoster
Ventral Tegmental Area
Cholinergic Neurons
Mazindol
Catalepsy
Dopamine D1 Receptors
Haloperidol
Mesencephalon
Basal Ganglia
Cholinergic Agents

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{5db79d2639b64439a03f8e8ccc8956ce,
title = "Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice",
abstract = "The neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) selected lines of mice differ more than 10-fold in the ED50 for catalepsy induced by a wide variety of neuroleptics with a high dopamine D2/D1 receptor activity ratio, e.g., haloperidol. The NR and NNR lines also differ significantly in dopamine D2 somatodendritic receptor density; within the substantia nigra zona compacta and the ventral tegmental area, the increases in the NNR line are on average 33 and 48{\%}, respectively. We now report that the NNR line has a higher number of dopamine neurons in the midrostral to the midcaudal aspect of the substantia nigra zona compacta. Within this region, the increase in dopamine cell number was on average 41{\%}. In contrast to these data, there was no difference in cell number between lines in the ventral tegmental area. Thus, the increase of midbrain dopamine D2 receptor density in the NNR line can only be accounted for in part by an increase in the number of dopamine neurons. Although the number of dopamine neurons in the substantia nigra zona compacta was increased in the NNR line, the density of dopamine terminals in the caudate-putamen as estimated by the [3H] mazindol technique was modestly but significantly higher (8{\%}) in the NR line. The selected lines also differed within the caudate-putamen in the number of cholinergic neurons. The NR line had a significantly higher number of cholinergic neurons in the rostral caudate-putamen. Overall, these data illustrate that selective breeding for neuroleptic response has yielded lines of mice with significant differences in both the cholinergic and dopaminergic systems of the basal ganglia.",
author = "Robert Hitzemann and Y. Qian and B. Hitzemann",
year = "1993",
language = "English (US)",
volume = "266",
pages = "431--438",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice

AU - Hitzemann, Robert

AU - Qian, Y.

AU - Hitzemann, B.

PY - 1993

Y1 - 1993

N2 - The neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) selected lines of mice differ more than 10-fold in the ED50 for catalepsy induced by a wide variety of neuroleptics with a high dopamine D2/D1 receptor activity ratio, e.g., haloperidol. The NR and NNR lines also differ significantly in dopamine D2 somatodendritic receptor density; within the substantia nigra zona compacta and the ventral tegmental area, the increases in the NNR line are on average 33 and 48%, respectively. We now report that the NNR line has a higher number of dopamine neurons in the midrostral to the midcaudal aspect of the substantia nigra zona compacta. Within this region, the increase in dopamine cell number was on average 41%. In contrast to these data, there was no difference in cell number between lines in the ventral tegmental area. Thus, the increase of midbrain dopamine D2 receptor density in the NNR line can only be accounted for in part by an increase in the number of dopamine neurons. Although the number of dopamine neurons in the substantia nigra zona compacta was increased in the NNR line, the density of dopamine terminals in the caudate-putamen as estimated by the [3H] mazindol technique was modestly but significantly higher (8%) in the NR line. The selected lines also differed within the caudate-putamen in the number of cholinergic neurons. The NR line had a significantly higher number of cholinergic neurons in the rostral caudate-putamen. Overall, these data illustrate that selective breeding for neuroleptic response has yielded lines of mice with significant differences in both the cholinergic and dopaminergic systems of the basal ganglia.

AB - The neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) selected lines of mice differ more than 10-fold in the ED50 for catalepsy induced by a wide variety of neuroleptics with a high dopamine D2/D1 receptor activity ratio, e.g., haloperidol. The NR and NNR lines also differ significantly in dopamine D2 somatodendritic receptor density; within the substantia nigra zona compacta and the ventral tegmental area, the increases in the NNR line are on average 33 and 48%, respectively. We now report that the NNR line has a higher number of dopamine neurons in the midrostral to the midcaudal aspect of the substantia nigra zona compacta. Within this region, the increase in dopamine cell number was on average 41%. In contrast to these data, there was no difference in cell number between lines in the ventral tegmental area. Thus, the increase of midbrain dopamine D2 receptor density in the NNR line can only be accounted for in part by an increase in the number of dopamine neurons. Although the number of dopamine neurons in the substantia nigra zona compacta was increased in the NNR line, the density of dopamine terminals in the caudate-putamen as estimated by the [3H] mazindol technique was modestly but significantly higher (8%) in the NR line. The selected lines also differed within the caudate-putamen in the number of cholinergic neurons. The NR line had a significantly higher number of cholinergic neurons in the rostral caudate-putamen. Overall, these data illustrate that selective breeding for neuroleptic response has yielded lines of mice with significant differences in both the cholinergic and dopaminergic systems of the basal ganglia.

UR - http://www.scopus.com/inward/record.url?scp=0027429818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027429818&partnerID=8YFLogxK

M3 - Article

C2 - 8101223

AN - SCOPUS:0027429818

VL - 266

SP - 431

EP - 438

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -